Patient Guide: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 84 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04502030
Status: COMPLETED
Condition: Chronic Lymphocytic Leukemia, Hypogammaglobulinemia
Phase: PHASE3

Find a Study Location Near You

This study is available at 84 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Saint Petersburg, Florida
  • Columbus, Georgia
  • Macon, Georgia
  • • And 81 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily